ArticlePDF Available

Antibacterial and Anticancer activity of ε{lunate}-poly-l-lysine (ε{lunate}-PL) produced by a marine Bacillus subtilis sp

Authors:
Journal of Basic Microbiology 2012, 52, 1 10 1
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.jbm-journal.com
Research Paper
Antibacterial and Anticancer activity of ε-poly-L-lysine (ε-PL)
produced by a marine Bacillus subtilis sp.
Nermeen A. El-Sersy1, Abeer E. Abdelwahab2, Samia S. Abouelkhiir1, Dunja-Manal Abou-Zeid3
and Soraya A. Sabry3
1 National Institute of Oceanography and Fisheries, Microbiology Laboratory Environmental Division,
Alanfushy Qayt bay, Alexandria, Egypt
2 Medical Biotechnology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI),
City for Scientific Research and Technology Application, Borg El-Arab, Alexandria, Egypt
3 Faculty of Science, Botany and Microbiology Department, El-Shatby, Alexandria, Egypt
A marine Bacillus subtilis SDNS was isolated from sea water in Alexandria and identified using
16S rDNA sequence analysis. The bacterium produced a compound active against a number of
gram negativeve bacteria. Moreover, the anticancer activity of this bacterium was tested
against three different human cell lines (Hela S3, HepG2 and CaCo). The highest inhibition
activity was recorded against Hela S3 cell line (77.2%), while almost no activity was recorded
towards CaCo cell line. HPLC and TLC analyses supported evidence that Bacillus subtilis SDNS
product is
ε
-poly-L-lysine. To achieve maximum production, Plackett-Burman experimental
design was applied. A 1.5 fold increase was observed when Bacillus subtilis SDNS was grown in
optimized medium composed of g/l: (NH4)2SO4, 15; K2HPO4, 0.3; KH2PO4, 2; MgSO4 7 H2O, 1;
ZnSO4 7 H2O, 0; FeSO4 7 H2O, 0.03; glucose, 25; yeast extract, 1, pH 6.8. Under optimized
culture condition, a product value of 76.3 mg/l could be obtained. According to available litera-
ture, this is the first announcement for the production of
ε
-poly-L-lysine (
ε
-PL) by a member of
genus Bacillus.
Keywords: ε-Poly-L-lysine / Bacillus subtilis / Plackett-Burman / Antibacterial / Anticancer
Received: June 16, 2011; accepted: August 18, 2011
DOI 10.1002/jobm.201100290
Introduction*
Multi-drug resistance is a world-wide problem, attrib-
uted to the extensive use of antibiotics, selection pres-
sure on bacterial strains and lack of new drugs, vac-
cines and diagnostic aids. These shortcomings lead to
an urgent global call for new antimicrobial drugs, par-
ticularly from natural resources [1].
Marine microorganisms represent a wide source of
yet undiscovered compounds that, besides unprece-
dented chemical structures, often possess interesting
biological activities [2]. They constitute a promising
source of unique metabolites with considerable phar-
maceutical and therapeutical potential. Common bio-
Correspondence: Prof. Dr. Nermeen Ahmed El-Sersy, National Insti-
tute of Oceanography and Fisheries, Microbiology Lab. Marine Environ-
mental Division, Qayetbay, Anfoushy, Alexandria, Egypt
E-mail: Nermeen_ok@yahoo.co.uk
Phone: 01006620217
logical assays usually focus on antimicrobial and cyto-
toxic activities as demonstrated throughout the litera-
ture [3].
Antimicrobial agents produced by Gram-positive bac-
teria have attracted much attention because of their
potential use as food preservatives. Some representa-
tives of Bacillus spp, such as B. subtilis and B. licheniformis,
are generally recognized as safe (GRAS) bacteria [4, 5].
ε
-Poly-L-lysine (
ε
-PL) is a basic homopolymer which
has strong antimicrobial activity against most gram-
positive and gram-negative bacteria, fungi and also
some kinds of viruses. Moreover, it is harmless to hu-
mans, biodegradable and has antitumor effect [6]. Thus,
it has been widely used in food manufacturing as a safe
preservative.
The nutritional and environmental conditions have a
great influence on production of antimicrobial agents.
To achieve maximum production, knowledge regarding
2 N. A. El-Sersy et al. Journal of Basic Microbiology 2012, 52, 1 10
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.jbm-journal.com
the environmental factors affecting this process needs
to be well identified. Experimental designs are excellent
techniques for optimization of culture conditions to
achieve optimal production [7].
Because of
ε
-poly-L-lysine has been only detected by
members of family Streptomycetaceae, it was thus aimed
in this study to explore marine environment for strain
with capability to produce the polymer. Optimization
study will be applied to maximize polymer production.
Moreover, the study will be extended to prove its anti-
bacterial and anticancer activity.
Materials and methods
Bacterial strains
Bacillus sp. SDNS used in this study was isolated from
marine water samples of Alexandria, Egypt. Test bacte-
ria included Gram positive (Staphylococcus aureus, Strepto-
coccus faecalis) and Gram negative (E. coli, Pseudomonas
aeruginosa, Vibrio fluvialis, Vibrio vulnificus, Vibrio sp. N2).
Strains were kindly provided by Microbiological lab,
National Institute of Oceanography and Fisheries
(NIOF).
Chemicals and reagents
Bacteriological media components, chemicals, solvents,
reagents and dyes, of analytical grade were obtained
from commercial suppliers.
HeLa S3 cell line PCCL-2.2
(HeLaS3 cell line slides (human cervix adenocarcinoma),
Human HeLa S3 cells were cultured in Ham’s F12K
medium, HepG2 cell line ATTC#HB.8065(HepG2 Hu-
man hepatocellular liver carcinoma cell line) Whole
Cell Lysate, CaCo cell line HTB-37(Caco2 (Human colo-
nic carcinoma cell line) Whole Cell Lysate, were ob-
tained from (Abcam, USA).
Growth condition
M3G medium [8] was used for seed culture preparation
and production of the homopolymer in shake flasks. It
contained (g/l): glucose, 50; yeast extract, 5; (NH4)2SO4,
10; KH2PO4, 1.36; K2HPO4, 0.8; MgSO4 7 H2O, 0.5;
ZnSO4 7 H2O, 0.04; and FeSO4 7 H2O, 0.03. The pH was
adjusted to 6.8 with NH4OH solution (2428%, w/v).
Glucose and yeast extract were autoclaved separately. A
standard inoculum (1%) was taken from previously
prepared seed cultures (OD600 ~ 0.81) and used to in-
oculate 50 ml portions of M3G medium dispensed in
100 ml flasks. Flasks were then incubated shaken at
160 rpm at 30 °C. Samples were taken regularly at time
intervals to measure growth and
ε
-PL concentration by
Itzhaki method [9].
Bacterial identification
DNA was isolated, purified and the region of 16S rDNA
was amplified using either universal primers or species-
specific primers. Genotypic characterization was per-
formed using 16S sequence analysis. Multiple align-
ments with sequences of most closely members and
calculations of levels of sequence similarity were car-
ried out using Bioedit [10]. Sequences of rRNA genes,
for comparison, were obtained from the NCBI database.
A phylogenetic tree was reconstructed by Bioedit [10].
Phenotypic characteristics were determined for the
selected isolate according to the standard methods [11].
Measurement of ε-poly-L-lysine
Samples were taken regularly at time intervals to
measure growth and
ε
-PL concentration by Itzhaki
method [9]. To measure the concentration of
ε
-PL, 1 ml
of 0.1 mM phosphate buffer and 2.0 ml 0.1 mM methyl
orange (MeO) solution were added to 1 ml of bacterial
supernatant. The mixture was vigorously shaken on a
reciprocal shaker at 30 °C and then centrifuged. The
optical density of resulting supernatant was measured
at 465 nm against an appropriate blank. Equivalent
ε
-PL
concentration was determined using the methyl orange
standard curve.
Optimization of nutritional factors
Cultivation medium optimization was performed using
the Plackett-Burman experimental design [12]. In this
experiment, seven independent variables were screened
in nine combinations organized according to the Plack-
ett-Burman design matrix. For each variable, a high (+)
and low (–) level was tested. All trials were performed
in triplicates and the averages of degradation observa-
tion results were treated as the response. The main
effect of each variable was determined with the follow-
ing equation:
Exi = (Σpi+ Σpi)/N
where Exi is the variable main effect, Σpi+ and Σpiare
ε
-PL
production responses in trials where the independent
variable (Xi) was present in high and low concentra-
tions, respectively, and N is the number of trials divided
by 2. All trials were performed in triplicates and the
averages of percentages of
ε
-PL production results were
treated as the responses. Verification of validity of the
optimum medium compared to the basal medium and
the Plackett-Burman reverse medium was applied.
Antibacterial activity
The antibacterial effect of the bacteria isolated was
studied using the agar diffusion method [13]. Nutrient
Journal of Basic Microbiology 2012, 52, 1 10
ε
-Poly-L-lysine (
ε
-PL) produced by a B. subtilis sp. 3
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.jbm-journal.com
agar plates were seeded with the test organisms includ-
ing Gram positive and Gram negative bacteria and
holes of 10 mm diameter were made in the plates using
a sterile cork borer. 50 μl of each supernatant were
transferred into each hole under aseptic conditions.
Plates were then incubated for 1 d at 37 °C. The anti-
microbial activity of the isolates was detected as clear
inhibition zone around holes and was measured (mm).
Anticancer activity
In order to evaluate the anticancer activity of the bacte-
rial filtrate, several steps were undertaken: lyophiliza-
tion, cytotoxicity test and effect of IC50 on three differ-
ent tumor cell lines. Lyophilization can be summarized
in three general steps: Freezing, primary drying and
secondary drying. 10 ml of filtrate were lyophilized and
converted into powder using a Telson lyophilizer
(Spain). Different concentrations (5, 25, 50, 75, 100 μg/
ml) of the powder were prepared and used in the sec-
ond step (cytotoxicity test). To measure cytotoxicity of
the examined compound, 5 × 104 lymphocyte cells were
seeded per well in 96 well plates and incubated in
RPMI1640 (Sigma-Aldrich Chemical Co) media contain-
ing different concentrations (5, 25, 50, 75, 100 μg/ml) of
the tested powder and incubated for 24 h in 5% CO2
incubator. Next, the media were removed and wells
were washed with Hank’s Balance Salt Solution (HBSS).
The fraction of viable lymphocytes was measured by
the MTT (3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetra-
zolium bromide).
In the MTT assay, yellow MTT is reduced to purple
formazan in the mitochondria of viable cells. 100 μl of
the MTT working solution (0.5 mg/ml) were added to
each well and incubated at 37 °C for 4 h. Next, media
were removed, wells were washed with PBS, and 100 μl
of dimethyl sulfoxide (DMSO) were added to solubilize
the formazan crystalline product. The absorbance was
measured with a plate reader at 570 nm and normal-
ized to the absorbance at 630 nm. Fraction of viable cell
was determined by dividing the normalized absorbance
of the test well to that of the control well [14]. Cytotox-
icity assay was performed on different human cell line
using the previously described method.
The anticancer activity of the substance was tested
using three different human cell lines (Hela S3, HepG2
and CaCo). Cells (2 × 104) were seeded per well in 96
well plates and incubated in Ham’s F-l2, RPMI and
DMEM, respectively for 24 h in 5% CO2 incubator for
cell attachment. Next, the media were changed with
media containing 10% of IC50 of the tested substances
and cells were incubated in that media for 24, 48 and
72 h. Media without any chemical was used as the nega-
tive control. At each time point, the media were re-
moved, wells were washed with PO4 Buffer Saline (PBS)
and fractions of viable cells were measured by the MTT
assay.
HPLC analysis
Culture supernatant of isolated bacteria, was subjected
to acid hydrolysis with 6 N HCl. The concentration of
L-lysine was determined using HPLC. Samples were pas-
sed through a Hypersil ODS, 5 μm column (4.6 × 250),
eluted with (A: 0.5 M CHCOOH at pH = 2.8; B: MeOH) at
a flow rate of 1 ml/min [15].
Partial purification and hydrolysis of Methyl Orange
(MeO) precipitating substance
The supernatant of isolated bacteria was adjusted to pH
2.5 with an HCl solution and saturated with a metha-
nol/acetone (3:1) mixture 30 to 70% after standing
overnight at 4 °C. The resulting precipitate was then
hydrolyzed as stated above. The hydrolyzed product
obtained was subjected to thin-layer chromatography
using ready prepared TLC plate’s silica gel 60 [MERCK].
Solvent system used as developer consisted of n-
butanol-acetic acid-pyridine-water (4:1 : 1 : 2); ninhydrin
reagent was used for visualization [15].
Results
Identification of bacterial isolate
DNA sequencing of 16S rDNA (the first1438 bp) of the
selected isolate, showed a highest similarity of 99.7% to
B. subtilis BAC-UFMT FJ025757.1 (Fig. 1) with GenBank
accession number of GU191141.
Bacillus subtilis SDNS formed mucoid creamy colonies.
Cells were Gram positive, endospore forming rods, Oxi-
dase and catalase positive. The bacterium hydrolysed
blood and was sensitive to all antibiotics tested (Flu-
cloxacillin FL5, Norfloxacin NOR10, Ampicillin/Sulbac-
tam SAM20, Gentamicin CN10, Imipenem IPM10, Eryr-
romycin E15, Ceftazidime CAZ30, Ampicillin AM10,
Ciprocin ciprofloxacin CIP5, Cephalerxin CL30 and
Cefadroxil CFR30).
Production of ε-PL in batch culture
As depicted in Fig. 2 in batch culture, cells exhibited
a lag phase of 3 h, followed by exponential growth
which extended till 14 h where maximum growth
(OD600 = 5.86) was achieved.
ε
-PL production started
after one hour of growth and showed highest titre
(71.7 mg/l) after 14 h of growth. On the other hand,
initial pH value (6.8) gradually decreased by time reach-
ing a value of 5.3 after 16 h.
4 N. A. El-Sersy et al. Journal of Basic Microbiology 2012, 52, 1 10
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.jbm-journal.com
Figure 1. Phylogenetic tree of isolate EL5. 16S rDNA-based den-
dogram showing the phylogenetic position of isolate EL5 among
representatives of related bacterial species. The tree was construct-
ed by Bioedit method [10]. Percentages (right) indicate phylogenetic
similarities.
Application of statistical design
(Plackett-Burman design)
The application of Plackett-Burman statistical design
was carried out in a ‘two phases’ of optimization ap-
proach. The first step was to screen for important fac-
tors and their levels that affect production process in
shaked flasks (Table 1). The second was the verification
experiments to validate the results under specific opti-
Figure 2. Growth and poly-lysine production of Bacillus sp. SDNS
grown on M3G medium for 24 h at 30 °C under shaken conditions
(160 rpm).
mized experimental conditions. All the experiments
were carried out in duplicates according to a design
matrix (Table 2), which was based on the number of
variables to be investigated. In the analysis of these
designs, usually only main effects are estimated. The
ε
-PL concentration (or the residual MeO) was measured
after 4 days of incubation (Table 2).
The production of
ε
-PL by Bacillus subtilis SDNS was
positively affected by KH2PO4, MgSO4 7 H2O and
(NH4)SO4, and negatively affected by yeast extract,
ZnSO4 7 H2O, K2HPO4 and glucose (Fig. 3). The polymer
production was mainly dependent on yeast extract and
KH2PO4. i.e. the high concentration of yeast extract had
the most significant negative effect on
ε
-PL production
and the high concentration of KH2PO4 had the most
significant positive effect on
ε
-PL production by Bacillus
subtilis SDNS. Therefore, decreasing the yeast extract
concentration and simultaneously increasing the
KH2PO4 concentration in the culture medium can in-
creased the
ε
-PL production. The significant variables
were identified by statistical analysis of the Plackett-
Burman experiment using the t-test supported by Exel
Table 1. Main effect and t-value results with factors examined as independent variables affecting
ε
-PL production and their levels
in the Plackett-Burman experimental design. Medium components are given in g l–1.
Levels Factors Symbols
Low level (–1) Basal medium (0) High level (+1)
Main effect
t
-value
(NH4)SO4 NH 5 10 15 3.475 0.25
K2HPO4 K2 0.3 0.8 1.3 –12.375 –0.96
KH2PO4 KH 0.86 1.36 2 14.375 1.15
MgSO4 7 H2O Mg 0.1 0.5 1 6.775 0.50
ZnSO4 7 H2O Zn 0.0 0.04 0.08 –18.675 –1.62
Glucose G 25 50 75 –2.825 –0.20
Yeast extract YE 1 5 10 –19.275 –1.69
Journal of Basic Microbiology 2012, 52, 1 10
ε
-Poly-L-lysine (
ε
-PL) produced by a B. subtilis sp. 5
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.jbm-journal.com
Table 2. The Plackett-Burman experimental design matrix for 7 factors.
Independent variable Eq. PL conc. (mg/l) Trials
NH K2 KH Mg Zn G YE
1 –1 –1 –1 +1 +1 +1 –1 59.7
2 +1 –1 –1 –1 –1 +1 +1 55.8
3 –1 +1 –1 –1 +1 –1 +1 24.1
4 +1 +1 –1 +1 –1 –1 –1 72.3
5 –1 –1 +1 +1 –1 –1 +1 76.3
6 +1 –1 +1 –1 +1 –1 –1 73.6
7 –1 +1 +1 –1 –1 +1 –1 73.6
8 +1 +1 +1 +1 +1 +1 +1 45.9
9 0 0 0 0 0 0 0 71.7
Figure 3. Elucidation of cultivation factors affecting ε-PL production
by Bacillus sp. SDNS (b) using Plackett-Burman experimental
design.
Microsoft Office to determine the statistical signifi-
cance of the measured response and calculate main
effects for Bacillus subtilis SDNS (Table 1). The anti- op-
timized medium was the opposite concentrations of the
optimized one and its growth medium formula for
Bacillus subtilis SDNS contained in (g/l): (NH4)SO4, 5;
K2HPO4, 1.3; KH2PO4, 0.86; MgSO4 7 H2O, 0.1; ZnSO4
7 H2O, 0.08; glucose, 75; yeast extract, 10. FeSO4 7 H2O
was added with constant value 0.03 g/l and pH 6.8.
Verification experiment
In order to validate the obtained data and to evaluate
the accuracy of the applied Plackett-Burman statistical
design, a verification experiment was carried out in
triplicates to predict the near optimum levels of inde-
pendent variables. The data were examined and com-
pared to the basal and anti-optimized medium. Data
revealed that the poly-L-lysine production raised by 1.5
fold for Bacillus subtilis SDNS when growing in opti-
mized medium (Fig. 4). We thus predict that in order to
produce the highest amount of poly-L-lysine, the me-
dium formula should be formulated as follows (g/l):
Figure 4. Verification experiment of the applied Plackett-Burman
statistical design by comparing the concentration of ε-PL produced
by Bacillus sp. SDNS growing on the resulting optimized medium
(OP.M), the basal medium (BM) and the anti-optimized medium
(A.OP.M).
(NH4)2SO4, 15; K2HPO4, 0.3; KH2PO4, 2; MgSO4 7 H2O,
1; ZnSO4 7 H2O, 0; FeSO4 7 H2O, 0.03; glucose, 25;
yeast extract, 1 and the expected yield could be up to
76.3 mg/l. pH 6.8.
Antibacterial activity
Data in Fig. 5 reveal that
ε
-PL of Bacillus subtilis SDNS
exhibited antagonistic effect against all Gram negative
tested bacteria, with variable degrees depending on
bacterial species. No effect was observed with the Gram
positive Staphylococcus aureus. These data were recorded
after incubation of plates for 24 h, extending incuba-
tion time did not show any change in zone measure-
ment (data not shown).
Anticancer activity
Anticancer activity was performed by first testing the
toxicity of culture filtrates and evaluates its activity
against three different cell lines: human cervix adeno-
carcinoma (HeLaS3), Human hepatocellular liver carci-
noma cell line (HepG2) and Human colonic carcinoma
cell line (Caco2).
6 N. A. El-Sersy et al. Journal of Basic Microbiology 2012, 52, 1 10
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.jbm-journal.com
Figure 5. Clear zone diameter expressed in cm produced by Bacil-
lus sp. SDNS against several microbes after 24 h incubation and at
37 °C.
The effect of culture supernatant of the bacterial
strain Bacillus subtilis SDNS on HepG2 tumor cell line
using MTT assay was employed giving rise a percentage
of inhibition of 56.2% after 72 h (Table 3).
Upon using the HelaS3 tumor cell line, the super-
natant of Bacillus subtilis SDNS showed almost 77.2%
inhibition after 72 h (Table 3).
The supernatant of the bacterial strain showed al-
most no activity towards Caco cell line (Fig. 6) Figs. 6A–
F represent photographs showing the effect of bacterial
extract on the three cell lines examined based on cell
count by microscopic observation.
HPLC and TLC analyses
HPLC was performed for the hydrolyzed products of
Bacillus subtilis SDNS strain. Fig. 7 shows the chroma-
tograms obtained in this experiment. Data reveal the
presence of L-lysine (the product of
ε
-PL hydrolysis) in
concentration of 9.15448 mg/ml. Hydrolysed product
was analysed by TLC which confirm the presence of
L-lysin (data not shown).
Discussion
It is widely accepted that new drugs, especially antibiot-
ics, are urgently required, and that the most propitious
source remains natural products. To explore new
sources of bioactive natural products the marine envi-
Table 3. The effect of culture supernatant of the bacterial strain
Bacillus subtilis SDNS on tumor cell line using MTT assay.
Time (h) % of Inhibition on tumor cell line
HepG2 Hela S3 CaCo
24 9.7 20.6 0.5
48 19.5 41.7 4
72 56.2 77.2 9.8
ronment wants particular attention, in view of the
remarkable diversity of microorganisms and metabolic
products [16].
ε
-PL possesses antimicrobial activity against a wide
spectrum of microbes and has been widely used in food
manufacturing as a safe preservative [17]. Its produc-
tion is limited to one family Streptomycetaceae [18]. In
this work, a screening study targeting bacterial strains
as producers of
ε
-PL was performed. Over one hundred
marine bacterial isolates were screened. This is the first
time to announce the isolation of marine Bacillus subtilis
SDNS capable of producing
ε
-PL, data not previously
reported according to literature available. Sea water
was required for growth of the bacterium and its me-
tabolism. Quantification of
ε
-PL was done using Itzhaki
method [9], a rapid and sensitive technique employed
by other investigator [19, 20]
Production of
ε
-PL by Bacillus subtilis SDNS began with
the beginning of bacterial growth and reached its
maximum at late exponential phase. This was accom-
panied by shifting of pH to acidic condition. The data
are in agreement with that previously reported by Yo-
shida & Nagasawa [21] with Streptomyces celluloflavus who
observed accumulation of the polymer under acidic
condition.
In order to maximize
ε
-PL production by Bacillus sub-
tilis SDNS an experimental design was employed. Plack-
ett-Burman design is one of the so-called “screening
designs”. Such designs are traditionally used for identi-
fying important factors from among many potential
factors [12]. In the analysis of these designs, usually
only main effects are estimated. M3G medium is the
conventional medium used for production of
ε
-PL as
reported in literature [20]. Under our experimental
conditions, glucose and ammonium sulfate appeared to
be the most important factors affecting
ε
-PL production
by Bacillus subtilis SDNS, on the contrary, yeast extract
had a negative effect. Our results agreed with those of
Shih and Shen [22] with Streptomyces albulus IFO 14147
except for Yeast extract which enhanced polymer pro-
duction. This could be due to the nature of the bacterial
species. We thus suggested an optimized formula con-
sisting of (g/l): (NH4)SO4, 15; K2HPO4, 0.3; KH2PO4, 2;
MgSO4 7 H2O, 1; ZnSO4 7 H2O, 0; FeSO4.7H2O, 0.03;
glucose, 25; yeast extract, 1 pH 6.8.
The amount produced by Bacillus subtilis SDNS could
reach up to 76.3 mg/l. The quantity produced is low
compared to that recorded in literature. S. albulus used
for commercial production produces 45 g/l [23],
whereas Kitatospora sp. produces 1.75 g/l without pH
control and 7.7 g/l after pH control as reported by Ouy-
ang et al. [24]. Also, Hirohara et al. [15] stated that
Journal of Basic Microbiology 2012, 52, 1 10 7
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.jbm-journal.com
(A) (B)
(C) (D)
(E) (F)
Figure 6. Photographs illustrating the difference between the bacterial extract of Bacillus subtilis SDNS (B) on the growth inhibition of
HepG2 tumor cell line compared to control (A); the difference between the bacterial extract of Bacillus subtilis SDNS (D) on the growth
inhibition of HelaS3 tumor cell line compared to control (C); difference between the bacterial extract of Bacillus subtilis SDNS (F) on the
growth inhibition of CaCo tumor cell line compared to control (H).
8 N. A. El-Sersy et al. Journal of Basic Microbiology 2012, 52, 1 10
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.jbm-journal.com
(a)
(b)
Figure 7. HPLC chromatograms of standard L-lysine (A), L-lysine produced by Bacillus sp. SDNS (B).
S. aureofaciens USE-82 produced the highest amount
among the isolated eight strains which produced
4.0 g/l. We thus speculate that further studies are re-
quired to improve the amount produced.
ε
-PL molecules are cationic, surface active agents due
to their positively charges amino groups in water, and
they have been shown to have a wide antimicrobial
spectrum by growth inhibition studies with yeast,
fungi, and Gram-positive or Gram-negative bacterial
species [25, 26]. Our data reveals that Bacillus subtilis
SDNS exhibited antagonistic effect against all Gram-
negative tested bacteria, with variable degrees depend-
ing on bacterial species. Whereas no effect was ob-
served with the Gram-positive Staphylococcus aureus,
growth of Streptococcus faecalis was inhibited.
Data obtained in the present study showed that Bacil-
lus subtilis SDNS metabolites potentially inhibited the
proliferation of HelaS3 cells with lethal concentration
LC71 and HepG2 cells with lethal concentration LC53.
These results may contribute in finding an alternative
for treatment of cancer and be used as a chemothera-
peutic drugs. With similarity to the data obtained in
this part of study Shlyakhovenko et al. [27] found after
extensive investigation that nucleoprotein fraction of
Bacillus subtilis 7025 (NPF) culture medium filtrate can
be effective as antitumor immunotherapeutic agents.
Another data obtained by Abe
et al
. [28], are in accord-
ance of our data as Bacillus sp. produced compounds
acting as antitumor agents. Parasporin-2 is a newly
classified Bacillus thuringiensis crystal toxin with strong
cytocidal activities toward human liver and colon can-
cer cells. Unfortunately, no data are available with
respect to the effect of metabolites produced by Bacillus
subtilis against both tumor cell lines studied through-
out this study HepG2 and HelaS3.
Journal of Basic Microbiology 2012, 52, 1 10
ε
-Poly-L-lysine (
ε
-PL) produced by a B. subtilis sp. 9
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.jbm-journal.com
Data of HPLC revealed the presence of L-lysine
(the product of
ε
-PL hydrolysis) in concentration of
9.15448 mg/ml. The culture filtrate was partially puri-
fied as previously reported [29, 30]. The product was
hydrolyzed and subjected to thin layer chromatography
(TLC) technique which is very popular in separating
components of hydrolysis.
The hydrolysate produced showed the presence of
L-lysine. These data are similar to those published by
Nishikawa and Ogawa [17]. More future study is re-
quired for the identification of the product.
Conclusion
Marine environment is a good source for valued species
that need to be explored. The main aim of the present
study was to explore our natural environments search-
ing for species producing the polymer
ε
-PL, due to the
limited number of organisms known till now to pro-
duce this polymer which limits its large scale produc-
tion. This product is of great economic importance.
Producing such polymer industrially in Egypt will save
millions of dollars (it is now sold for 3500 LE/g).
References
[1] Sundaram, S., Priyanka D., Shalini, P., 2011. In vitro evalu-
ation of antibacterial activities of crude extracts of Witha-
nia somnifera (Ashwagandha) to bacterial pathogens. Asian
J. Biotechnol., 3(2), 194–199.
[2] Sepcic, K., Polona, Z., Nina, Gunde-C., 2011. Low water
activity induces the production of bioactive metabolites
in halophilic and halotolerant fungi. Mar. Drugs, 9, 43
58.
[3] Debbab, A., Amal, H.A., Wen, H.L., Peter, P., 2010. Mini
review. Bioactive compounds from marine bacteria and
fungi. Microbial Biotechnol., 3(5), 544 563.
[4] El-Sersy, N.A., Ebrahim, H.A.H., Abou-Elela G.M., 2010.
Response surface methodology as a tool for optimizing
the production of antimicrobial agents from Bacillus liche-
niformis SN2. Curr. Res. Bacteriol., 3, 1 14.
[5] Pakpitcharoena, A., Potivejklub, K., Kanjanavasa, P., Aree-
kita, S., Chansir, K., 2008. Biodiversity of thermotolerant
Bacillus sp. producing biosurfactants, biocatalyst and an-
timicrobial agents. Sci. Asia, 34, 424 431.
[6] Szende, B., Gy Szökán, E., Tyihá, K.P.R., Gáborjányi, M.A.,
Khlafulla, A.R., 2002. Antitumor effect of lysine-isopep-
tides. Cancer Cell International 2: 4. This article is avai-
lable from: http://www.cancerci.com/content/2/1/4, Cell x.
[7] El-Sersy, N.A., Abou-Elela, G.M., Abd-Elnaby, H., Ebrahim,
H.A.H., El-Toukhy, N.M.K., 2010. Optimization, economi-
zation and characterization of cellulase produced by ma-
rine Streptomyces ruber. Afr. J. Biotechnol., 9(38), 6355
6364.
[8] Kahar, P., Iwata, T., Hiraki, J., Park, Y.E., Okabe, M., 2001.
Enhancement of
ε
-polylysine production by Streptomyces
albulus strain 410 using pH control. J. Biosci. Bioeng., 9(2),
190 194.
[9] Itzhaki, R.F., 1972. Colorimetric method for estimating
polylysine and poly-arginine. Anal. Biochem., 50, 569
574.
[10] Hall, T.A., 1999. BioEdit: a user-friendly biological se-
quence alignment editor and analysis program for Win-
dows 95/98/NT. Nucl. Acids. Symp. Ser., 41, 95–98.
[11] Ventosa, A., Quesada, F., Rodríguez-Varela, F., Ruiz-Berra-
quero,F., Ramos-Cormenzana, A., 1982. Numerical taxo-
nomy of moderately Gram negative rods. J. Gen. Micro-
biol., 128, 1959 1968.
[12] Plackett, R.L., Burman, J.P., 1946. The design of optimum
multifactorial experiments. Biometrika, 33(4), 305–325.
[13] Abou-Elela, G.M., El-Sersy, N. A., El-Sheuawy, M.A., Abd-
Elnabi, H., IbraInm, H.A.H., 2009. Bio-control of Vibrio flu-
vialis in aquaculture by mangrove (Avicennia marina) seeds
extracts. Res. J. Microbiol., 4(1), 38 48.
[14] Xuezhong, H., Junyu, M., Angel, E.M., Weijie, X., Esmaiel,
J., 2007. Cytotoxicity of paclitaxel in biodegradable self-
assembled core-shell poly (lactide-co-glycolide ethylene
oxide fumarate) nanoparticles. Pharmac. Res., 25(7),
1552 1562.
[15] Hirohara, H., Saimura, M., Takehara, M., Miyamoto, M.,
Ikezaki, A., 2007. Substantially monodispersed poly(
ε
-L-
lysine) frequently occurred in newly isolated strains of
Streptomyces sp. Appl. Microbiol. Biotechnol., 76, 1009
1016.
[16] Bull, A.T., Stach, J.E.M., 2007. Marine actinobacteria: new
opportunities for natural product search and discovery.
Trends Microbiol., 15, 491 499.
[17] Nishikawa, M., Ogawa, K., 2002. Distribution of microbes
producing antimicrobial
ε
-poly-L-lysine polymers in soil
microflora determined by a novel method. Appl. Environ.
Microbiol., 68(7), 3575 3581.
[18] Saimura, M., Takahara, M., Mizukami, S., Kataoka, K.,
Hirohara, H., 2008. Biosynthesis of nearly monodispersed
poly(
ε
-L-lysine) in Streptomyces species. Biotechnol. Lett.,
30, 377 385.
[19] Takehara, M., Saimura, M., Inaba, H., Hirohara, H., 2008.
Poly (
γ
-L-diaminobutanoic acid), a novel poly (amino acid),
coproduced with poly(
ε
-L-lysine) by two strains of Strepto-
myces celluloflavus. FEMS Microbiol Lett., 286, 110 117.
[20] Shih, I.L., Shen, M.H., Van, Y.T., 2006. Microbial synthesis
of poly (
ε
-lysine) and its various applications. Bioresource
Technol., 97(9), 1148 1159.
[21] Yoshida, T., Nagasawa, T., 2003.
ε
-Poly-L-lysine: microbial
production, biodegradation and application potential.
Appl. Microbiol. Biotechnol., 62, 21 26.
[22] Shih, I.L., Shen, M.H., 2006b. Optimization of cell growth
and poly(
ε
-lysine) production in batch and fed-batch cul-
tures by Streptomyces albulus IFO 14147. Proc. Biochem., 41,
1644 1649.
[23] Shima, S., Oshima, S., Sakai, H., 1983. Biosynthesis of
ε-poly-L-lysine by washed mycelium of Streptomyces albulus
No-346. Nippon Nogeikagaku Kaishi, 57, 221–226.
10 N. A. El-Sersy et al. Journal of Basic Microbiology 2012, 52, 1 10
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.jbm-journal.com
[24] Ouyang, J., Xu, H., Li, S., Zhu, H. et al. 2006. Production of
ε
-poly-lysine by newly isolated Kitatospora sp. PL6-3. Bio-
technol., 1, 1459 1463.
[25] Hiraki, J., Ichikawa, T., Ninomiya, S.I., Seki, H. et al., 2003.
Use of ADME studies to confirm the safety of
ε
-polylysine
as a preservative in food. Reg. Toxicol. Pharm., 37, 328
340.
[26] Yu, H., Huang, Y., Huang, Q., 2009. Synthesis and charac-
terization of novel antimicrobial emulsifiers from
ε
-poly-
lysine. J. Agric. Food Chem., 58(2), 1290 1295.
[27] Shlyakhovenko, V.A., Olishevsky, S.V., Kozak, V.V., Ya-
nish, Y.V., Rybalko, S.L., 2003. Anticancer and immu-
nostimulatory effects of nucleoprotein fraction of Bacillus
subtilis 7025 culture medium filtrate. Exp. Oncol., 25,
119 123.
[28] Abe, Y., Shimada, H., Kitada, S., 2008. Raft-targeting and
oligomerization of parasporin-2, a Bacillus thuringiensis
crystal protein with anti-tumour activity. J. Biochem.,
143(2), 269-275.
[29] Hirohara, H., Takehara, M., Saimura, M., Masayuki, A.,
Miyamoto, M., 2006. Biosynthesis of poly(
ε
-L-lysine)s in
two newly isolated strains of Streptomyces sp. Appl. Micro-
biol. Biotechnol., 73(2), 321 331.
[30] Shih, I.L., Shen, M.H., 2006. Application of response sur-
face methodology to optimize production of poly-
ε
-lysine
by Streptomyces albulus IFO 14147. Enz. Microbi. Technol.,
39(1), 15 21.

Supplementary resource (1)

... ε-poly-l-Lysine (ε-PLL) is a cationic biopolymer isolated from the marine bacterium Bacillus subtilis, responsible for the antibacterial and anticancer activity shown by this microorganism [1]. The same peptide is also produced by the marine bacterial strain PL26 of Bacillus licheniformis, isolated from the west coast of India [2]. ...
... The industrial production of ε-PLL makes use of a mutant of Streptomyces albulus [9]. Still, it can be conveniently achieved also using the above mentioned strain PL26 of marine bacterium Bacillus licheniformis starting from waste material from biodiesel manufacturing industries [1,2]. On the other side, α-poly-l-lysine (α-PLL) is a synthetic poly(amino acid) successfully used in different biotechnological applications, e.g., in biomass production by microalgae Chlorella ellipsoidea [10]. ...
... Mar. Drugs 2020, 18, x 2 of 12 use of a mutant of Streptomyces albulus [9]. Still, it can be conveniently achieved also using the above mentioned strain PL26 of marine bacterium Bacillus licheniformis starting from waste material from biodiesel manufacturing industries [1,2]. On the other side, α-poly-L-lysine (α-PLL) is a synthetic poly(amino acid) successfully used in different biotechnological applications, e.g., in biomass production by microalgae Chlorella ellipsoidea [10]. ...
Article
Full-text available
ε-poly-l-Lysine (ε-PLL) peptide is a product of the marine bacterium Bacillus subtilis with antibacterial and anticancer activity largely used worldwide as a food preservative. ε-PLL and its synthetic analogue α,ε-poly-l-lysine (α,ε-PLL) are also employed in the biomedical field as enhancers of anticancer drugs and for drug and gene delivery applications. Recently, several studies reported the interaction between these non-canonical peptides and DNA targets. Among the most important DNA targets are the DNA secondary structures known as G-quadruplexes (G4s) which play relevant roles in many biological processes and disease-related mechanisms. The search for novel ligands capable of interfering with G4-driven biological processes elicits growing attention in the screening of new classes of G4 binders. In this context, we have here investigated the potential of α,ε-PLL as a G4 ligand. In particular, the effects of the incubation of two different models of G4 DNA, i.e., the parallel G4 formed by the Pu22 (d[TGAGGGTGGGTAGGGTGGGTAA]) sequence, a mutated and shorter analogue of the G4-forming sequence known as Pu27 located in the promoter of the c-myc oncogene, and the hybrid parallel/antiparallel G4 formed by the human Tel22 (d[AGGGTTAGGGTTAGGGTTAGGG]) telomeric sequence, with α,ε-PLL are discussed in the light of circular dichroism (CD), UV, fluorescence, size exclusion chromatography (SEC), and surface plasmon resonance (SPR) evidence. Even though the SPR results indicated that α,ε-PLL is capable of binding with µM affinity to both the G4 models, spectroscopic and SEC investigations disclosed significant differences in the structural properties of the resulting α,ε-PLL/G4 complexes which support the use of α,ε-PLL as a G4 ligand capable of discriminating among different G4 topologies.
... Bio surfactant was partially purified by cold acetone precipitation. Three volumes of chilled acetone was added to the crude bio surfactant solution and allowed to stand for (15)(16)(17)(18)(19)(20) h at 4°C. The precipitate was collected by centrifugation at 10,000rpm for 30 min and the resulting pellet served as partially purified bio surfactant it was further allowed to be evaporating to dryness to remove residual acetone after which it was dissolved in sterile water. ...
... Different lipopeptides produced by Bacillus, Pseudomonas, and Serratia species have exhibited antitumor activity against various human cancer cells. 19,20 Bio surfactants have been shown to have effects on cancer cells. For instance, the lipopeptidesurfactin was found to induce apoptosis in breast cancer cells. ...
... The same genus Marine Bacillus subtilis sp, can also produce an L-lysine biopolymer Epsilon-poly-L-lysine with antibacterial and anticancer activity. Studies have shown that Epsilon-poly-L-lysinet has obvious cytotoxicity on the cervical adenocarcinoma cell HeLaS3 and liver cancer cell HepG2 [24]. Pseudomonas libanensis m9-3 produces a cyclic lipopeptide named viscosin with extensive antibacterial and antitumor activities. ...
Article
Full-text available
Owing to its unique mechanism of abundant pathogen-associated molecular patterns in antitumor immune responses, bacteria-based cancer immunotherapy has recently attracted wide attention. Compared to traditional cancer treatments such as surgery, chemotherapy, radiotherapy, and phototherapy, bacteria-based cancer immunotherapy exhibits the versatile capabilities for suppressing cancer thanks to its preferentially accumulating and proliferating within tumors. In particular, bacteria have demonstrated their anticancer effect through the toxins, and other active components from the cell membrane, cell wall, and dormant spores. More importantly, the design of engineering bacteria with detoxification and specificity is essential for the efficacy of bacteria-based cancer therapeutics. Meanwhile, bacteria can deliver the cytokines, antibody, and other anticancer theranostic nanoparticles to tumor microenvironments by regulating the expression of the bacterial genes or chemical and physical loading. In this review, we illustrate that naïve bacteria and their components can serve as robust theranostic agents for cancer eradication. In addition, we summarize the recent advances in efficient antitumor treatments by genetically engineering bacteria and bacteria-based nanoparticles. Further, possible future perspectives in bacteria-based cancer immunotherapy are also inspected.
... As a secondary metabolite, ε-PL is mainly produced from sustainable resources such as sugars and glycerol through microbial fermentation by various Streptomycetaceae, a few filamentous fungi and some Bacilli [18,19], but the production of ε-PL is unstable and dependent on cell density [20]. Recently, with the development of genetic engineering, bioinformatics, and advanced precision instruments and testing equipment, microbial ɛ-PL fermentation has been systematically investigated, focusing on screening of higher ɛ-PL-producing strains [21], development of new fermentation mode, regulation of the polymerization degree of ɛ-PL and understanding the biosynthetic mechanism of ɛ-PL [22], optimization of culture conditions [23], and illuminating the inhibitory effect of ε-PL on microorganisms [24]. Therefore, the intention of this review is to summarize recent developments in ɛ-PL fermentation, from strain-breeding to process optimization, focusing particularly on the update progress on the regulation mechanism of microbial ɛ-PL. ...
Article
Full-text available
The naturally occurring homo-polyamide biopolymer, ε-poly-L-lysine (ε-PL) consists of 25–35 L-lysine residues with amide linkages between α-carboxyl groups and ε-amino groups. ɛ-PL exhibits several useful properties because of its unusual structure, such as biodegradability, water solubility, no human toxicity, and broad-spectrum antibacterial activities; it is widely applied in the fields of food, medicine, clinical chemistry and electronics. However, current industrial production of ε-PL is only performed in a few countries. Based on an analysis of the physiological characteristics of ε-PL fermentation, current advances that enhance ε-PL fermentation, from strain improvement to product isolation are systematically reviewed, focusing on: (1) elucidating the metabolic pathway and regulatory mechanism of ε-PL synthesis; (2) enhancing biosynthetic performance through mutagenesis, fermentation optimization and metabolic engineering; and (3) understanding and improving the biological activity and functional properties of ε-PL. Finally, perspectives on engineering and exploiting ε-PL as a source material for the production of various advanced materials are also discussed, providing scientific guidelines for researchers to further improve the ε-PL fermentation process.
... The effect might be due to the presence of bioactive molecules produced by probiotics. Other LAB studies have reported bioactive molecules such parasporin-2Aa1 (from Bacillus thuringiensis strain A1547), 74 epsilon-poly-L-lysine (from marine Bacillus subtilis SDNS), 75 and polyphosphate (poly P) (from L. brevis SBL8803). 76 PFT, which is mainly constituted of L. kefiri P-IF, does have unique characteristics among LAB, namely that 1) due to surface carbohydrate chains, P-IF can grow three-dimensionally whereas other L. kefiri strains grow lengthwise, and 2) P-IF can produce carbonic acid by using galactose as a carbon source. ...
Article
Full-text available
Introduction Oxidative stress is a key contributor to aging and age-related diseases. In the present study, we examine the protective effects of PFT, a novel kefir product, against age-associated oxidative stress using aged (10-month-old) mice. Methods Mice were treated with PFT orally at a daily dose of 2 mg/kg body weight over 6 weeks, and antioxidant status, protein oxidation, and lipid peroxidation were studied in the brain, liver, and blood. Results PFT supplementation significantly reduced the oxidative stress biomarkers malondialdehyde (MDA) and nitric oxide; reversed the reductions in glutathione (GSH) levels, total antioxidant capacity (TAC), and anti-hydroxyl radical (AHR) content; enhanced the antioxidant enzyme activities of glutathione peroxidase (GPx), catalase (CAT), and superoxide dismutase (SOD); inhibited the liver enzyme levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT); significantly reduced triglyceride (TG), total cholesterol (TC), and low density lipoprotein (LDL) levels; and significantly elevated high density lipoprotein (HDL) levels. Interestingly, PFT supplementation reversed the oxidative changes associated with aging, thus bringing levels to within the limits of the young control mice in the brain, liver, and blood. We also note that PFT affects the redox homeostasis of young mice and that it is corrected post-treatment with PFT. Conclusion Our findings show the effectiveness of dietary PFT supplementation in modulating age-associated oxidative stress in mice and motivate further studies of PFT’s effects in reducing age-associated disorders where free radicals and oxidative stress are the major cause.
... The effects of bioactive molecules secreted by probiotics may represent another mechanism by which probiotics exert their effects. A few of these bioactive molecules have been discussed in the literature, including parasporin-2Aa1 (from Bacillus thuringiensis strain A1547) [51], epsilon-poly-Llysine (from marine Bacillus subtilis SDNS) [52], and polyphosphate (poly P) (from L. brevis SBL8803) [53]. ...
Article
Full-text available
Background: The popularity of fermented foods such as kefir, kuniss, and tofu has been greatly increasing over the past several decades, and the ability of probiotic bacteria to exert anticancer effects has recently become the focus of research. While we have recently demonstrated the ability of the novel kefir product PFT (Probiotics Fermentation Technology) to exert anticancer effects in vitro, here we demonstrate its ability to inhibit Ehrlich ascites carcinoma (EAC) in mice. Methods: Mice were inoculated intramuscularly with EAC cells to develop solid tumors. PFT was administered orally (2 g/kg/day) to mice 6 days/week, either 2 days before tumor cell inoculation or 9 days after inoculation to mice bearing solid tumors. Tumor growth, blood lymphocyte levels, cell cycle progression, apoptosis, apoptotic regulator expression, TNF-α expression, changes in mitochondrial membrane potential (MMP), PCNA, and CD4+ and CD8+ T cells in tumor cells were quantitatively evaluated by flow cytometry or RT-PCR. Further studies in vitro were carried out where EAC cells along with several other human cancer cell lines were cultured in the presence of PFT (0-5 mg/mL). Percent cell viability and IC50 was estimated by MTT assay. Results: Our data shows that PFT exerts the following: 1) inhibition of tumor incidence and tumor growth; 2) inhibition of cellular proliferation via a marked decrease in the expression of tumor marker PCNA; 3) arrest of the tumor cell cycle in the sub-G0/G1 phase, signifying apoptosis; 4) induction of apoptosis in cancer cells via a mitochondrial-dependent pathway as indicated by the up-regulation of p53 expression, increased Bax/Bcl-2 ratio, decrease in the polarization of MMP, and caspase-3 activation; and 5) immunomodulation with an increase in the number of infiltrating CD4+ and CD8+ T cells and an enhancement of TNF-α expression within the tumor. Conclusions: PFT reduces tumor incidence and tumor growth in mice with EAC by inducing apoptosis in EAC cells via the mitochondrial-dependent pathway, suppressing cancer cell proliferation, and stimulating the immune system. PFT may be a useful agent for cancer prevention.
... 346 with a characteristic peptide bond consisting of 25-30 L-lysine residues between the α-carboxyl groups and εamino groups (Shima and Sakai, 1977;Takehara et al., 2010). In addition, recent studies revealed that other microorganisms, such as Streptomyces M-Z18 , Streptomyces griseus (Li et al., 2011), Streptomyces aureofaciens (Takehara et al., 2010) Bacillus subtilis (El-Sersy et al., 2012) and Bacillus subsp. PL6-3 (Ouyang et al., 2006) are capable of synthesizing ε-PL. ...
Article
Microbial secondary metabolites produced by Streptomyces are applied to control plant diseases. ε-poly-l-lysine (ε-PL) is a non-toxic food preservative, but the potential application of ε-PL as a microbial fungicide in agriculture has rarely been reported. In this study, Alternaria alternata (A. alternata) was used to reveal the effect and mode of action for ε-PL on the plant pathogenic fungi. The results showed that ε-PL effectively inhibited necrotic-lesion development caused by A. alternata on tobacco. Mycelial growth was also significantly inhibited in vitro by 100 μg/ml ε-PL using in vitro analysis. Moreover, 25 μg/ml ε-PL inhibited spore germination and induced abnormal morphological development of A. alternata hyphae. To clarify the molecular-genetic antifungal mechanisms, we selected several crucial genes involved in the development and pathogenesis of A. alternata and studied their expression regulated by ε-PL. Results of real-time quantitative PCR showed that a mycelium morphology and pathogenic process related cyclic adenosine monophosphate protein (cAMP) dependent protein kinase A (PKA), Alternaria alternata cAMP-dependent protein kinase catalytic subunit (AAPK1) and the early infection-related glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were down-regulated after ε-PL treatment. The results provide novel insights for the application of ε-PL in the control of plant diseases caused by A. alternata.
... To study the anticancer activity of the purified L-asparaginase produced by A. terreus against three cell lines namely, Hep-G2 (human Hepatocellular carcinoma), MCF-7 (human mammary gland adenocarcinoma) and HCT-116 (colon carcinoma), different steps of lyophilization, cytotoxicity test (measured by MTT assay) and effect of the median inhibitory dose (IC50) were carried out 22,23 . ...
Article
Full-text available
L-asparaginase (E.C.3.5.1.1) is an enzyme responsible for hydrolysis of L-asparagine into aspartic acid and ammonia, and has its significant applications in the therapeutics and food technology. It was produced by the marine Aspergillus terreus and precipitated by 65% ammonium sulphate, followed by purification using gel filtration on Sephadex G-100 and DEAE-cellulose ion exchange chromatography, which yielded 11.96 fold purification. The molecular weight of the purified L-asparaginase was approximately 85 kDa, determined by a sodium dodecyl sulphate polyacrylamide gel electrophoresis. L-asparaginase showed high affinity for L-asparagine with a Km of 31.5 mM and Vmax of 500 U/ml. The optimum pH and temperature of the purified enzyme were 5.8 and 40 o C, respectively. The L-asparaginase enzyme was stable from pH 4 to 5.8 and stable up to 70 o C. The effect of activators and inhibitors was studied providing that CdCl2 , Pb Cl2 , and Hg Cl2 strongly inhibited the enzyme activity, while Na Cl highly enhanced activity. Anticancer activity of the purified L-asparaginase was detected against HCT-116, Hep-G2 and MCF-7 cell lines with IC50 ranged from 3.79-12.6 µg/ml.
... e-PL is a microbial-derived homo-poly amino acid that is synthesized by polymerization of lysine via e-PL synthetase (PLS). e-PL possesses antibacterial and anticancer activities and has been approved as food preservative or dietary agent in Japan and United States [49]. e-PL was produced by Streptomyces species such as Streptomyces albulus. ...
Article
Full-text available
Nutraceuticals are important natural bioactive compounds that confer health-promoting and medical benefits to humans. Globally growing demands for value-added nutraceuticals for prevention and treatment of human diseases have rendered nutraceuticals a multi-billion dollar market. However, supply limitations and extraction difficulties from natural sources such as plants, animals or fungi, restrict the large-scale use of nutraceuticals. Metabolic engineering via microbial production platforms has been advanced as an eco-friendly alternative approach for production of value-added nutraceuticals from simple carbon sources. Microbial platforms like the most widely used Escherichia coli and Saccharomyces cerevisiae have been engineered as versatile cell factories for production of diverse and complex value-added chemicals such as phytochemicals, prebiotics, polysaccaharides and poly amino acids. This review highlights the recent progresses in biological production of value-added nutraceuticals via metabolic engineering approaches.
Article
Full-text available
The study investigated silver nanoparticles (AgNPs) synthesized extracellularly using an actinomycete isolated from sediment of the Suez Gulf, Red Sea, Egypt. Screening for biosynthesis of AgNPs revealed that among the forty one actinomycetes tested, only two exhibited the ability to synthesize AgNPs with antibacterial activity. The most potent isolate was selected and identified as Streptomyces rochei MHM13 (accession number KR108310) on the basis of morphological and physiological properties, together with 16S rRNA sequence. The biosynthesized AgNPs significantly inhibited the growth of medically important pathogenic bacteria (Vibrio fluvialis, Pseudomonas aeruginosa, Salmonella typhimurium, Vibrio damsela, Escherichia coli, Bacillus subtilis, Staphylococcus aureus, Bacillus cereus). The biosynthesized AgNPs were achieved by addition of silver nitrate (1 mM) to the culture supernatant and monitored by colour change after incubation then characterized by UV–Visible spectrophotometer, X-ray, Fourier transform-infrared spectroscopy and scanning electron microscopy. The obtained AgNPs are spherical in shape with a particle size of 22–85 nm. Plackett–Burman design was employed for optimization of the culture conditions for the production of AgNPs by S. rochei. Synergetic effect of AgNPs with six different antibiotics was evaluated. The microbiologically synthesized silver nanoparticles acted as an anti-biofouling agent. Moreover, silver nanoparticles exhibited a significant degree of anticancer activity against five different tumour cell lines.
Article
Full-text available
Antitumor and immunostimulatory effects of nucleoprotein fraction of Bacillus subtilis 7025 (NPF) cultural medium filtrate have been investigated. Although a number of important questions remains to be answered our experiments indicated that NPF of Bacillus subtilis 7025 cultural medium filtrate can be effective as antitumor immunotherapeutic agent, has significant immunostimulatory effects and augments NK cell cytotoxicity and IFN-α/γ-producing activity of leukocytes.
Article
Full-text available
A study was made of 516 randomly selected isolates of moderately halophilic bacteria from solar salterns showing salinities between 8.8 and 40.0% (w/v) total salts, located in S.E. Spain. After purification, many cytological, physiological, biochemical, nutritional and antibiotic sensitivity characters were determined for 106 selected saltern isolates and two reference strains. Data were coded and analysed by numerical techniques using the Jaccard coefficient (S j), and clusters of strains were obtained by average linkage (UPGMA) analysis. Nine major phenons were found at the 72.5% similarity level. The properties of each phenon are given, their taxonomic affinities are discussed, and typical reference strains are suggested. Almost all the strains were related to genera known to contain marine species. A large number of the strains could be tentatively assigned to the genus Vibrio, suggesting that this may be an abundant taxon of moderately halophilic Gram-negative rods in solar salterns.
Article
Thermotolerant bacteria isolated from soil and water samples taken from 76 hot springs in Thailand were investigated for their biosurfactant, biocatalytic, and antimicrobial properties. DNA samples purified from 148 pure isolates were PCR amplified using primers specific for the 16S rDNA hypervariable region of the genus Bacillus. The DNAPAR phylogenetic tree clearly demonstrated that these isolates were related to Bacillus niacini, B. korensis, B. firmus, B. flexus, B. megaterium, B. pumilus, B. licheniformis, B. subtilis, B. fusiformis, Oceanobacillus picturae, Anoxybacillus gonensis, Aneurinibacillus thermoaerophilus, and Anoxybacillus flavithermus. Determination of their biosurfactant properties using the oil spreading technique indicated that B. megaterium (SR8.5), B. licheniformis (CM8.2), and B. pumilus (SR4.4) possessed the highest biosurfactant activity. In addition, lipase, cellulase, and xylanase activities were detected from B. megaterium (CP1, SR8.5), B. pumilus (PR3.2), and B. licheniformis (CM1.1, LP3, MH11.3, LP3, NN2.3, PR2.3, PR2.2, PT1.2). While B. subtilis (CM3.3, CM14.1) had the highest cellulase activity, most isolates showed either undetectable or relatively low lipase and xylanase activities.
Article
Biosynthesis of ∊-poly-L-lysine (n=25~30, ∊-PL) by washed mycelium of Streptomyces albulus No-346 was investigated. The maximum ∊-PL accumulation occurred at pH 4.0~4.5. Among nitrogen sources, ammonium sulfate was remarkably effective for ∊-PL production. The washed mycelium at optimum pH accumulated more than 8-times the amount of ∊-PL compared with growing culture. Succinate, acetate, lactate and nitrate inhibited ∊-PL production. l-Lysine added exogenously was incorporated into ∊-PL. D-Lysine was not incorporated into the polymer and inhibited the polymerization process of l isomer. © 1983, Japan Society for Bioscience, Biotechnology, and Agrochemistry. All rights reserved.
Article
Marine bacteria and fungi are of considerable importance as new promising sources of a huge number of biologically active products. Some of these marine species live in a stressful habitat, under cold, lightless and high pressure conditions. Surprisingly, a large number of species with high diversity survive under such conditions and produce fascinating and structurally complex natural products. Up till now, only a small number of microorganisms have been investigated for bioactive metabolites, yet a huge number of active substances with some of them featuring unique structural skeletons have been isolated. This review covers new biologically active natural products published recently (2007-09) and highlights the chemical potential of marine microorganisms, with focus on bioactive products as well as on their mechanisms of action.
Article
Thermotolerant bacteria isolated from soil and water samples taken from 76 hot springs in Thailand were investigated for their biosurfactant, biocatalytic, and antimicrobial properties. DNA samples purified from 148 pure isolates were PCR amplified using primers specific for the 16S rDNA hypervariable region of the genus Bacillus. The DNAPAR phylogenetic tree clearly demonstrated that these isolates were related to Bacillus niacini, B. korensis, B. firmus, B. flexus, B. megaterium, B. pumilus, B. licheniformis, B. subtilis, B. fusiformis, Oceanobacillus picturae, Anoxybacillus gonensis, Aneurinibacillus thermoaerophilus , and Anoxybacillus flavithermus. Determination of their biosurfactant properties using the oil spreading technique indicated that B. megaterium (SR8.5), B. licheniformis (CM8.2), and B. pumilus (SR4.4) possessed the highest biosurfactant activity. In addition, lipase, cellulase, and xylanase activities were detected from B. megaterium (CP1, SR8.5), B. pumilus (PR3.2), and B. licheniformis (CM1.1, LP3, MH11.3, LP3, NN2.3, PR2.3, PR2.2, PT1.2). While B. subtilis (CM3.3, CM14.1) had the highest cellulase activity, most isolates showed either undetectable or relatively low lipase and xylanase activities.
Article
Response surface methodology (RSM) were employed to study the effect of yeast extract, glucose, ammonium sulfate, and initial medium pH on the production of poly-ɛ-lysine (ɛ-PL) by Streptomyces albulus IFO 14147 in shaken flask cultures. The results of first-order factorial design experiments showed that the linear terms of yeast extract, glucose, and ammonium sulfate had significant effect on ɛ-PL production, but the initial medium pH at the tested range exhibited insignificant effect on ɛ-PL production. It was predicted that decreasing the concentration of yeast extract, glucose, and ammonium sulfate enhance ɛ-PL production. Furthermore, the results of the four-factor-two-level (2⁴) factorial experiments indicated that the first order with interactions model (R² value of 0.9660) appeared to be more adequate than the pure first-order model (R² value of 0.8759). The optimum composition was then assessed by using a central composite design (CCD). The experimental results of CCD were fitted with a second-order polynomial equation by a multiple regression analysis. The determination coefficient R² was 0.816, the Fisher F-test was significant at upper 5% level and the lack of fit was insignificant at 5% level. All of these indicated a good adequacy of the second-order polynomial model proposed to explain the data observed.